Literature DB >> 11747093

Role of nitric oxide and nitric oxide synthases in experimental models of denervation and reinnervation.

D S Tews1.   

Abstract

Nitric oxide (NO) is a short-living free molecule synthesized by three different isoforms of nitric oxide synthases (NOS)-neuronal NOS, endothelial NOS, and inducible NOS-associated with neuromuscular transmission, muscle contractility, mitochondrial respiration, and carbohydrate metabolism in skeletal muscle. Neuronal NOS is constitutively expressed at the muscle fiber sarcolemma linked to the dystrophin-glycoprotein complex and concentrated at the neuromuscular endplate. There is increasing evidence that altered expression of neuronal NOS plays a role in muscle fiber damage in neuromuscular diseases such as dystrophinopathies and denervating disorders. Although there have been some previous conflicting results on the neuronal NOS expression pattern in denervated muscle fibers, it is now well established that denervation is associated with a down-regulation and disappearance of sarcolemmal neuronal NOS at synaptic/extrasynaptic or both sites. As NO has been shown to induce collapse and growth arrest on neuronal growth cones, down-regulation of sarcolemmal neuronal NOS may contribute to axonal regeneration and attraction to muscle fibers aiming at the formation of new motor endplates providing reinnervation and reconstitution of NOS expression. As NO serves as a retrograde messenger, it may trigger structural downstream events responsible for neuromuscular synaptogenesis and preventing polyneural innervation. Nevertheless, decreased NO production in denervation reduces the cytoprotective scavenger function of NO for superoxide anions promoting oxidative stress that is likely to be involved in muscle fiber damage and death. However, the multifaced role of NOS and NO under physiological and pathological conditions remains poorly understood on the basis of the current knowledge. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747093     DOI: 10.1002/jemt.1169

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  7 in total

Review 1.  Early postdenervation depolarization is controlled by acetylcholine and glutamate via nitric oxide regulation of the chloride transporter.

Authors:  Frantisek Vyskocil
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP.

Authors:  Roberta Buono; Chiara Vantaggiato; Viviana Pisa; Emanuele Azzoni; Maria Teresa Bassi; Silvia Brunelli; Clara Sciorati; Emilio Clementi
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

3.  Contribution of nitrergic nerve in canine gingival reactive hyperemia.

Authors:  Shigeru Shimada; Kazuo Todoki; Yoichi Omori; Toshizo Toyama; Masato Matsuo; Satoko Wada-Takahashi; Shun-Suke Takahashi; Masaichi-Chang-Il Lee
Journal:  J Clin Biochem Nutr       Date:  2015-03-01       Impact factor: 3.114

4.  Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ.

Authors:  Aman Patel; Junling Zhao; Yongping Yue; Keqing Zhang; Dongsheng Duan; Yi Lai
Journal:  Skelet Muscle       Date:  2018-11-22       Impact factor: 4.912

5.  Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function.

Authors:  Junling Zhao; Hsiao Tung Yang; Lakmini Wasala; Keqing Zhang; Yongping Yue; Dongsheng Duan; Yi Lai
Journal:  Mol Med       Date:  2019-07-02       Impact factor: 6.354

Review 6.  Master Regulators of Muscle Atrophy: Role of Costamere Components.

Authors:  Luisa Gorza; Matteo Sorge; Laura Seclì; Mara Brancaccio
Journal:  Cells       Date:  2021-01-03       Impact factor: 6.600

Review 7.  Response and adaptation of skeletal muscle to denervation stress: the role of apoptosis in muscle loss.

Authors:  Parco M Siu; Stephen E Alway
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.